Our Team
Our Team
By Clinicians and Researchers, Shaping the Future of Medicine
By Clinicians and Researchers, Shaping the Future of Medicine
PathCal was founded by experts from the Hassanpour Lab at the Geisel School of Medicine and Dartmouth Health.
PathCal was founded by experts from the Hassanpour Lab at the Geisel School of Medicine and Dartmouth Health.
Core Team
Core Team
PathCal Leadership
PathCal Leadership
Saeed Hassanpour, Ph.D.
Chairman
Saeed Hassanpour, Ph.D.
Chairman
Saeed Hassanpour, Ph.D.
Chairman
Roshan Babu, M.S.
Chief Executive Officer
Roshan Babu, M.S.
Chief Executive Officer
Roshan Babu, M.S.
Chief Executive Officer
Arief Suriawinata, M.D.
Chief Medical Officer
Arief Suriawinata, M.D.
Chief Medical Officer
Arief Suriawinata, M.D.
Chief Medical Officer
Bruno Korbar, Ph.D.
Chief Technology Officer
Bruno Korbar, Ph.D.
Chief Technology Officer
Bruno Korbar, Ph.D.
Chief Technology Officer
Our Journey
The Road to Discovery
March, 2024: PathCal founded.
June, 2025: Pivotal study utilizing longitudinal EMA and deep learning to predict OUD published.
September, 2025: Initiated regulatory engagement with the FDA for SaMDs supporting diagnosis and prognosis.
February, 2025: Key partnerships established with premier academic centers in Asia and South America.
February, 2025: Key partnerships established with premier academic centers in Asia and South America.
July, 2025: Novel patent issued for attention-based classification of high-resolution microscopy images.
July, 2025: Novel patent issued for attention-based classification of high-resolution microscopy images.
October, 2025: Engaged with pharma partners to explore DDT pathways supporting pivotal clinical trials.
October, 2025: Engaged with pharma partners to explore DDT pathways supporting pivotal clinical trials.
Our Journey
Our Journey
The Road to Discovery
The Road to Discovery
March, 2024: PathCal founded.
March, 2024: PathCal founded.
February, 2025: Key partnerships established with premier academic centers.
February, 2025: Key partnerships established with premier academic centers.
June, 2025: Pivotal study utilizing longitudinal EMA and deep learning to predict OUD published.
June, 2025: Published study using EMA and DL to predict OUD.
July, 2025: Patent issued for attention-based classification of microscopy images.
July, 2025: Patent issued for attention-based classification of microscopy images.
September, 2025: Initiated regulatory engagement with the FDA for SaMDs supporting diagnosis and prognosis.
September, 2025: Began regulatory engagement with the FDA for SaMDs aiding diagnosis and prognosis.
October, 2025: Engaged with pharma partners to explore DDT pathways supporting pivotal clinical trials.
October, 2025: Engaged with pharma partners to explore DDT pathways supporting pivotal clinical trials.
February, 2025: Key partnerships established with premier academic centers in Asia and South America.
July, 2025: Novel patent issued for attention-based classification of high-resolution microscopy images.
October, 2025: Engaged with pharma partners to explore DDT pathways supporting pivotal clinical trials.
Workflow
Optimizing the Digital Workflow
Optimizing the Digital Workflow
Streamlining the Path to Precise Laboratory Results
Streamlining the Path to Precision in Histopathology
Streamlining the Path to Precision in Histopathology
Optimizing the Digital Workflow
Streamlining the Path to Precision in Histopathology
"AI has what we sometimes lose – patience. It works until a solution is found. In a field where consistency, empathy and outcomes matter, this is transformational."
"AI has what we sometimes lose – patience. It works until a solution is found. In a field where consistency, empathy and outcomes matter, this is transformational."
Suneeta Reddy, M.D.
Managing Director of Apollo Hospitals